Essilor strengthens its operations in France with the acquisition of Interactif Visuel Système

Fri Jan 11, 2013 12:30am EST

* Reuters is not responsible for the content in this press release.

CHARENTON-LE-PONT, France--(Business Wire)--
Regulatory News: 

Essilor (Paris:EI) has announced the acquisition of 68.3% of the capital of
Interactif Visuel Système (IVS),a global leader in technological sales support
solutions for opticians. IVS designs, develops and sells a wide range of sales
support and ophthalmic measurement solutions, under the Activisu® brand. They
include the Visioffice® measuring column, designed jointly with Essilor, that
allows eyecare professionals to dispense Varilux® premium lenses, including the
latest Varilux® S 4D. Created in Paris, France over 15 years ago, IVS has more
than 80 employees and generates revenue of around €20 million. 

IVS`s solutions are present across five continents and represent some 30,000
software licenses in over 17,000 points of sale. At the forefront of
technological innovation, these solutions are protected by patents on ophthalmic
measurement-taking, combining live measurement by video stream,
three-dimensional modeling of the eye and simulation of visual behavior
strategies. IVS is also present in the digital media market, through its
subsidiary Activ`screen. 

In addition to having a strong culture of innovation, fostered by the creative
drive of its founders Benoist Monot and Pascal Thomet, IVS is a good strategic
fit with Essilor. The partnership allows Essilor to respond to the growing
demand for lens personalization, to forge closer ties with eyecare professionals
and to enhance its range of services for them. IVS`s technologies will also
enable Essilor to accelerate the deployment of its technological innovations and
its next generation lenses. In the future, the combined expertise of IVS and
Essilor will create a richer and more competitive range of products and services
for all eyecare professionals. 

Speaking about this partnership, Hubert Sagnières, Chairman and Chief Executive
Officer, said, "IVS technologies, combined with the strengths of our Instrument
Division, will allow us to distribute high performance measurement tools more
rapidly across all market segments throughout the world, in order to meet rising
demand for personalized lenses. This partnership also illustrates Essilor`s
ongoing commitment to meeting optician clients` needs for differentiating
high-end solutions, as well as to making innovations more widely accessible."

With this transaction, Essilor is continuing to expand in its domestic market,
while maintaining its commitment to partnering the global deployment of
innovative small and medium-sized companies in its sector. 

About Essilor

The world`s leading ophthalmic optics company, Essilor designs, manufactures and
markets a wide range of lenses to improve and protect eyesight. Its corporate
mission is to enable everyone around the world to access lenses that meet his or
her unique vision requirements. To support this mission, the Company allocates
around €150 million to research and development every year, in a commitment to
continuously bring new, more effective products to market. Essilor`s flagship
brands are Varilux®, Crizal®, Definity®, Xperio®, OptifogTM and Foster Grant®.
It also develops and markets equipment, instruments and services for eyecare

Essilor reported consolidated revenue of €4.2 billion in 2011 and employs around
48,700 people in some 100 countries. It operates 19 plants, a total of 390
prescription laboratories and edging facilities, as well as several research and
development centers around the world.

For more information, please visit

The Essilor share trades on the NYSE Euronext Paris market and is included in
the EuroStoxx 50 and CAC 40 indices.

Codes and symbols: ISIN: FR0000121667; Reuters: ESSI.PA; Bloomberg: EI:FP.

Investor Relations and Financial Communication
Véronique Gillet - Sébastien Leroy - Ariel Bauer
Phone: +33 (0)1 49 77 42 16
Media Relations
Maïlis Thiercelin
Phone: +33 (0)1 49 77 45 02 

Copyright Business Wire 2013
Comments (0)
This discussion is now closed. We welcome comments on our articles for a limited period after their publication.